Health Financial Statements From 2010 to 2024
Health Sciences financial statements provide useful quarterly and yearly information to potential Health Sciences Gr investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Health Sciences financial statements helps investors assess Health Sciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Health Sciences' valuation are summarized below:Health Sciences Gr does not presently have any fundamental trends for analysis.
This module can also supplement various Health Sciences Technical models . Check out the analysis of Health Sciences Correlation against competitors.
Check Health Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Health Sciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . Health financial statements analysis is a perfect complement when working with Health Sciences Valuation or Volatility modules.
Health |
Health Sciences Gr Company Current Valuation Analysis
Health Sciences' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Health Sciences Current Valuation | 39.41 K |
Most of Health Sciences' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Health Sciences Gr is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Health Sciences Gr has a Current Valuation of 39.41 K. This is 100.0% lower than that of the Food & Staples Retailing sector and 100.0% lower than that of the Consumer Staples industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Health Sciences Gr Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Health Sciences's current stock value. Our valuation model uses many indicators to compare Health Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Health Sciences competition to find correlations between indicators driving Health Sciences's intrinsic value. More Info.Health Sciences Gr is one of the top stocks in return on asset category among its peers. It also is one of the top stocks in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Health Sciences' earnings, one of the primary drivers of an investment's value.About Health Sciences Financial Statements
Health Sciences stakeholders use historical fundamental indicators, such as Health Sciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although Health Sciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Health Sciences' assets and liabilities are reflected in the revenues and expenses on Health Sciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Health Sciences Gr. Please read more on our technical analysis and fundamental analysis pages.
Health Sciences Group Inc., through its subsidiaries, provides various products used in nutritional supplements and functional foods and beverages in the United States. Health Sciences Group was founded in 1996 as Centurion Properties Development Corporation and changed its name to iGoHealthy.com in 2000. Health Sciences is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Health Pink Sheet
Health Sciences financial ratios help investors to determine whether Health Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Health with respect to the benefits of owning Health Sciences security.